ChromoGenics AB (STO:CHRO)
Sweden
· Delayed Price · Currency is SEK 9.78
0.00 (0.00%)
Inactive · Last trade price
on Sep 30, 2024
ChromoGenics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 9.25 | 15.7 | 24.44 | 29.23 | 19.5 | 46.37 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | - | - | Upgrade
|
| Revenue | 9.25 | 15.7 | 24.44 | 29.23 | 19.5 | 46.37 | Upgrade
|
| Revenue Growth (YoY) | -59.03% | -35.76% | -16.37% | 49.86% | -57.94% | 312.56% | Upgrade
|
| Cost of Revenue | 12.03 | 8.62 | 21.15 | 20.48 | 19.36 | 49.59 | Upgrade
|
| Gross Profit | -2.79 | 7.08 | 3.3 | 8.75 | 0.14 | -3.22 | Upgrade
|
| Selling, General & Admin | 51.65 | 53.24 | 58.54 | 66.41 | 52.31 | 65.71 | Upgrade
|
| Other Operating Expenses | -2.08 | -1.89 | -2.69 | 0.91 | 0.2 | -0.48 | Upgrade
|
| Operating Expenses | 54.48 | 55.82 | 59.22 | 69.61 | 57.49 | 73.16 | Upgrade
|
| Operating Income | -57.27 | -48.75 | -55.93 | -60.86 | -57.35 | -76.38 | Upgrade
|
| Interest Expense | -5.61 | -4.31 | -1.66 | -3.98 | -5.77 | -3 | Upgrade
|
| Interest & Investment Income | 0.53 | 0.55 | 0.6 | 0.1 | 0.07 | 0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 0.99 | 0.41 | 1.3 | Upgrade
|
| Other Non Operating Income (Expenses) | 43.7 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -18.65 | -52.51 | -56.98 | -63.75 | -62.65 | -78.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.08 | 0.12 | 0.18 | Upgrade
|
| Pretax Income | -18.65 | -52.51 | -56.98 | -63.53 | -62.48 | -77.85 | Upgrade
|
| Income Tax Expense | -0 | -0 | -0.01 | - | - | - | Upgrade
|
| Net Income | -18.65 | -52.51 | -56.98 | -63.53 | -62.48 | -77.85 | Upgrade
|
| Net Income to Common | -18.65 | -52.51 | -56.98 | -63.53 | -62.48 | -77.85 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 3 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 3 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 320.54% | 638.96% | 110.54% | 207.06% | 141.09% | - | Upgrade
|
| EPS (Basic) | -4.19 | -19.81 | -158.84 | -372.90 | -1125.96 | -3382.66 | Upgrade
|
| EPS (Diluted) | -4.22 | -19.81 | -158.84 | -372.90 | -1125.96 | -3383.00 | Upgrade
|
| Free Cash Flow | -42.28 | -40.97 | -61.05 | -69.76 | -69.21 | -130.51 | Upgrade
|
| Free Cash Flow Per Share | -9.51 | -15.46 | -170.18 | -409.44 | -1247.32 | -5670.82 | Upgrade
|
| Gross Margin | -30.12% | 45.07% | 13.48% | 29.94% | 0.72% | -6.94% | Upgrade
|
| Operating Margin | -619.46% | -310.46% | -228.80% | -208.25% | -294.07% | -164.70% | Upgrade
|
| Profit Margin | -201.73% | -334.41% | -233.10% | -217.39% | -320.35% | -167.89% | Upgrade
|
| Free Cash Flow Margin | -457.34% | -260.96% | -249.74% | -238.68% | -354.88% | -281.45% | Upgrade
|
| EBITDA | -53.89 | -45.81 | -52.88 | -58.77 | -53.17 | -71.24 | Upgrade
|
| EBITDA Margin | - | -291.73% | -216.32% | -201.08% | -272.61% | -153.62% | Upgrade
|
| D&A For EBITDA | 3.38 | 2.94 | 3.05 | 2.09 | 4.18 | 5.14 | Upgrade
|
| EBIT | -57.27 | -48.75 | -55.93 | -60.86 | -57.35 | -76.38 | Upgrade
|
| EBIT Margin | - | - | -228.80% | -208.25% | -294.07% | -164.70% | Upgrade
|
| Revenue as Reported | 55.07 | 19.61 | 29.35 | 31.44 | 17.82 | 39.89 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.